3.00
Genprex Inc (GNPX) 最新ニュース
Genprex files prospectus supplement for up to $75 million at-the-market offering By Investing.com - Investing.com Australia
Genprex files prospectus supplement for up to $75 million at-the-market offering - Investing.com Australia
Genprex Announces $75 Million Stock Offering - TipRanks
Genprex, Inc. Announces $75 Million Stock Offering - TradingView
Can Genprex Inc. (2DE0) stock sustain revenue momentumWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
How Genprex Inc. stock benefits from tech adoption2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Is Genprex Inc. stock attractive for retirement portfoliosJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Genprex Inc. (GNPX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Genprex Inc. (2DE0) stock attracts wealthy investorsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
Is Genprex Inc. (2DE0) stock at risk of policy regulationWeekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Will Genprex Inc. (2DE0) stock outperform global peersJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Published on: 2025-11-19 22:26:30 - newser.com
Is Genprex Inc. (2DE0) stock undervalued at current priceWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targets2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Will Genprex Inc. (2DE0) stock remain on Wall Street radarBull Run & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-19 13:34:52 - newser.com
Can Genprex Inc. (2DE0) stock beat analyst consensusEntry Point & Free Verified High Yield Trade Plans - newser.com
MSN Money - MSN
Genprex Expands Clinical Trials with New Site Addition - TipRanks
Genprex Expands Clinical Trials for Lung Cancer Therapy - TradingView
[8-K] Genprex, Inc. Reports Material Event | GNPX SEC FilingForm 8-K - Stock Titan
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials - PR Newswire
Can Genprex Inc. (2DE0) stock ride next bull market cycleJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Is Genprex Inc. (2DE0) stock a top pick for value investors2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
Can technical indicators confirm Genprex Inc.’s reversalEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Why Genprex Inc. stock remains a top recommendationMarket Risk Analysis & Real-Time Volume Trigger Notifications - newser.com
Analyzing drawdowns of Genprex Inc. with statistical toolsIPO Watch & Entry Point Strategy Guides - newser.com
大文字化:
|
ボリューム (24 時間):